antisense drugs
Could safety scupper Ionis, Pfizer’s cholesterol drug vupanorsen?
Phil Taylor
antisense drugs, cardiovascular, cholesterol, evinacumab, Ionis Pharmaceuticals, Pfizer, Regeneron
0 Comment
NICE relents and okays Akcea’s rare disease drug Waylivra for NHS use
Phil Taylor
Akcea Therapeutics, antisense drugs, Familial Chylomicronaemia Syndrome, Ionis Pharmaceuticals, NHS, NICE, rare disease
0 Comment
News/ News/ R&D/ Top stories
Ionis deal delivers for GSK as HBV drug hits the mark in phase 2
Phil Taylor
antisense drugs, GlaxoSmithKline, hepatitis B, infectious disease, Ionis
0 Comment
Roche takes on development of potential Huntington’s breakthrough
Andrew McConaghie
antisense drugs, Huntington's disease, Ionis Pharmaceuticals
0 Comment